Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Reason
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Classification
Class III
Status
Terminated
Lot
Lots: X220317A and X220318A, exp. date 09/25
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.